|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 | Glaxosmithkline Corporate Intellectual Property -uw2220 patentsThe following is a sampling of recent Glaxosmithkline Corporate Intellectual Property -uw2220 patent applications (USPTO Patent Application #, Patent Title) sorted by month.September 2010 - Glaxosmithkline Corporate Intellectual Property -uw2220 patents 20100223746 - Novel device February 2009 - Glaxosmithkline Corporate Intellectual Property -uw2220 patents 20090036442 - N-aroyl cyclic amine derivatives as orexin receptor antagonists August 2006 - Glaxosmithkline Corporate Intellectual Property -uw2220 patents 20060183182 - Enzyme substrate March 2006 - Glaxosmithkline Corporate Intellectual Property -uw2220 patents 20060051776 - Gene manipulation method using homologous recombination ### This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Corporate Intellectual Property -uw2220 in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Corporate Intellectual Property -uw2220 with additional patents listed. Browse our Agent directory for other possible listings. ### FreshPatents.com Support - Terms & Conditions |